Reported Standalone quarterly numbers for Norris Medicines are:
Net Sales at Rs 0.72 crore in June 2024 down 23.4% from Rs. 0.95 crore in June 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 0.37 crore in June 2024 up 40.45% from Rs. 0.61 crore in June 2023.
EBITDA stands negative at Rs. 0.15 crore in June 2024 up 61.54% from Rs. 0.39 crore in June 2023.
Norris Medicine shares closed at 13.87 on August 16, 2024 (BSE) and has given -39.70% returns over the last 6 months and 15.58% over the last 12 months.
Story continues below Advertisement
| Norris Medicines | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 0.72 | 1.49 | 0.95 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 0.72 | 1.49 | 0.95 | | EXPENDITURE | | Consumption of Raw Materials | 0.55 | 0.62 | 1.13 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.38 | -0.40 | -0.77 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.34 | 0.41 | 0.60 | | Depreciation | 0.13 | 0.14 | 0.14 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.37 | 0.37 | 0.37 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.29 | 0.35 | -0.53 | | Other Income | 0.01 | 0.03 | -- | | P/L Before Int., Excpt. Items & Tax | -0.28 | 0.38 | -0.53 | | Interest | 0.08 | 0.11 | 0.09 | | P/L Before Exceptional Items & Tax | -0.37 | 0.26 | -0.61 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.37 | 0.26 | -0.61 | | Tax | -- | 0.09 | -- | | P/L After Tax from Ordinary Activities | -0.37 | 0.17 | -0.61 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.37 | 0.17 | -0.61 | | Equity Share Capital | 9.93 | 9.93 | 9.93 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.37 | 0.17 | -0.61 | | Diluted EPS | -0.37 | 0.17 | -0.61 | | EPS After Extra Ordinary | | Basic EPS | -0.37 | 0.17 | -0.61 | | Diluted EPS | -0.37 | 0.17 | -0.61 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
